GSK3 alpha 抗体
Quick Overview for GSK3 alpha 抗体 (ABIN232113)
抗原
See all GSK3 alpha (GSK3a) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            特异性
- Ni-NTA purified truncated recombinant GSK3 alpha expressed in E. Coli strain BL21 (DE3)
- 
                                            免疫原
- 
                        Recombinant human GSK3A / GSK3 Alpha.
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: ELISA (1:10000), IHC, WB (1:500 - 1:2000)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Ascites.
 
- 
                                            
- 
    - GSK3 alpha (GSK3a) (Glycogen Synthase Kinase 3 alpha (GSK3a))
- 
                                            别名
- GSK3A / GSK3 Alpha
- 
                                            背景
- 
                        Name/Gene ID: GSK3A
 Subfamily: GSK-3
 Family: Protein Kinase
 Synonyms: GSK3A, GSK-3 alpha, GSK3 alpha
- 
                                            基因ID
- 2931
- 
                                            UniProt
- P49840
- 
                                            途径
- PI3K-Akt Signaling, WNT signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, cAMP Metabolic Process, Cellular Glucan Metabolic Process, Regulation of Muscle Cell Differentiation, Regulation of G-Protein Coupled Receptor Protein Signaling, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, BCR Signaling, Warburg Effect
 抗原
- 
                    
 
                                     
                                     
                                    